Literature DB >> 17197085

Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein.

Leah Selby1, Chunzhao Zhang, Qian-Quan Sun.   

Abstract

This study focused on the cytoarchitectonic and morphological differences in GABA-releasing interneurons between adult Fmr1 knock-out (FMR1KO) and wild-type (WT) mice in the somatosensory cortex. Our results showed a robust reorganization of neocortical, but not hippocampal inhibitory circuits in the FMR1KO mouse. The reorganization is characterized by a significant reduction (20%, p<0.001) in the densities of parvalbumin (PV)-positive, but not calbindin (CB) and calretinin (CR)-positive interneurons. A significant enlargement of soma size and an altered lamina distribution of PV but not CR and CB cells was also observed. Additionally, there was a modest but significant increase in TrkB-immunoreactivity in PV-positive cells in the FMR1KO mouse. These results provide the first report showing significant alterations of GABA-releasing interneurons in the mouse model of fragile X syndrome. Uncovering the changes in specific GABAergic inhibitory circuits could help understand mechanisms underlying the behavior deficits of fragile X syndrome and autism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17197085      PMCID: PMC1839948          DOI: 10.1016/j.neulet.2006.11.062

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  BDNF regulates the expression of fragile X mental retardation protein mRNA in the hippocampus.

Authors:  Maija Castrén; Katariina E Lampinen; Riitta Miettinen; Eija Koponen; Ilkka Sipola; Cathy E Bakker; Ben A Oostra; Eero Castrén
Journal:  Neurobiol Dis       Date:  2002-10       Impact factor: 5.996

2.  Quantitative analysis of neurons and glial cells in the rat somatosensory cortex, with special reference to GABAergic neurons and parvalbumin-containing neurons.

Authors:  J Q Ren; Y Aika; C W Heizmann; T Kosaka
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

3.  Major effects of sensory experiences on the neocortical inhibitory circuits.

Authors:  Yuanyuan Jiao; Chunzhao Zhang; Yuchio Yanagawa; Qian-Quan Sun
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

4.  Analysis of neocortex in three males with the fragile X syndrome.

Authors:  V J Hinton; W T Brown; K Wisniewski; R D Rudelli
Journal:  Am J Med Genet       Date:  1991-12-01

5.  Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: a preliminary report.

Authors:  L J Miller; D N McIntosh; J McGrath; V Shyu; M Lampe; A K Taylor; F Tassone; K Neitzel; T Stackhouse; R J Hagerman
Journal:  Am J Med Genet       Date:  1999-04-02

Review 6.  Dendritic spine structural anomalies in fragile-X mental retardation syndrome.

Authors:  S A Irwin; R Galvez; W T Greenough
Journal:  Cereb Cortex       Date:  2000-10       Impact factor: 5.357

7.  Decreased GABA(A) receptor expression in the seizure-prone fragile X mouse.

Authors:  Abdeslem El Idrissi; Xiao-Hua Ding; Jason Scalia; Ekkhart Trenkner; W Ted Brown; Carl Dobkin
Journal:  Neurosci Lett       Date:  2004-12-23       Impact factor: 3.046

8.  Somatosensory cortical barrel dendritic abnormalities in a mouse model of the fragile X mental retardation syndrome.

Authors:  Roberto Galvez; Anjali R Gopal; William T Greenough
Journal:  Brain Res       Date:  2003-05-02       Impact factor: 3.252

Review 9.  The mGluR theory of fragile X mental retardation.

Authors:  Mark F Bear; Kimberly M Huber; Stephen T Warren
Journal:  Trends Neurosci       Date:  2004-07       Impact factor: 13.837

10.  Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.

Authors:  P W Frankland; Y Wang; B Rosner; T Shimizu; B W Balleine; E M Dykens; E M Ornitz; A J Silva
Journal:  Mol Psychiatry       Date:  2004-04       Impact factor: 15.992

View more
  103 in total

Review 1.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

Review 2.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 3.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

Review 4.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

Review 5.  Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Authors:  Reymundo Lozano; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 6.  Fragile X syndrome and targeted treatment trials.

Authors:  Randi Hagerman; Julie Lauterborn; Jacky Au; Elizabeth Berry-Kravis
Journal:  Results Probl Cell Differ       Date:  2012

Review 7.  The state of synapses in fragile X syndrome.

Authors:  Brad E Pfeiffer; Kimberly M Huber
Journal:  Neuroscientist       Date:  2009-03-26       Impact factor: 7.519

8.  Estrogen Treatment Reverses Prematurity-Induced Disruption in Cortical Interneuron Population.

Authors:  Sanjeet Panda; Preeti Dohare; Samhita Jain; Nirzar Parikh; Pranav Singla; Rana Mehdizadeh; Damon W Klebe; George M Kleinman; Bokun Cheng; Praveen Ballabh
Journal:  J Neurosci       Date:  2018-07-23       Impact factor: 6.167

9.  Regulation of GABAA receptors by fragile X mental retardation protein.

Authors:  Baosong Liu; Lijun Li; Juan Chen; Zefen Wang; Zhiqiang Li; Qi Wan
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-09-10

10.  Impairment of cortical GABAergic synaptic transmission in an environmental rat model of autism.

Authors:  Anwesha Banerjee; Francisco García-Oscos; Swagata Roychowdhury; Luis C Galindo; Shawn Hall; Michael P Kilgard; Marco Atzori
Journal:  Int J Neuropsychopharmacol       Date:  2012-12-11       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.